Abstract
Objective
We conducted a meta-analysis of current literature to assess whether bariatric surgery(BS) has a positive effect on reducing the risk of multiple myeloma(MM).
Methods
Relevant studies meeting the criteria were systematically reviewed using databases such as PubMed, Web of Science, Embase (Ovid platform), MEDLINE, and the Cochrane Library. The meta-analysis utilized hazard ratios (RR) and 95% confidence intervals (CI) to analyze the correlation between BS and the risk of MM. STATA software (version 12.0) was employed for the meta analysis.
Results
The meta-analysis included 10 eligible studies, involving 2,452,503 patients with obesity. The results demonstrated a significant reduction in the risk of multiple myeloma in patients with obesity after bariatric surgery compared to non-surgical patients with obesity (RR = 0.51, 95%CI: 0.31–0.84). Subgroup analyses revealed a decreased probability of develo** multiple myeloma in European patients with obesity and North American patients with obesity who underwent bariatric surgery. Studies with a sample size greater than or equal to 100,000 indicated a significantly reduced risk of multiple myeloma in patients with obesity undergoing bariatric surgery compared to the non-surgical group (RR: 0.45, 95%CI: 0.23–0.88, P < 0.02). Two publications before 2010 showed no significant difference in the incidence of multiple myeloma between the surgical and non-surgical groups (RR: 0.61, 95% CI: 0.14–2.63, P = 0.504), while publications after 2010 demonstrated a reduced incidence in the surgical group (RR: 0.51, 95% CI: 0.30–0.86, P = 0.012).
Conclusion
Our meta-analysis results suggest a reduced risk of multiple myeloma in patients with obesity following bariatric surgery.
PROSPERO Registration
CRD42023485668
Graphical Abstract
![](http://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11695-024-07059-x/MediaObjects/11695_2024_7059_Figa_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-024-07059-x/MediaObjects/11695_2024_7059_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-024-07059-x/MediaObjects/11695_2024_7059_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-024-07059-x/MediaObjects/11695_2024_7059_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-024-07059-x/MediaObjects/11695_2024_7059_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-024-07059-x/MediaObjects/11695_2024_7059_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs11695-024-07059-x/MediaObjects/11695_2024_7059_Fig6_HTML.png)
Similar content being viewed by others
Data Availability
Statement All data generated or analyzed during this study are included in this article. Further inquiries can be directed to the corresponding author.
References
Dragano NRV, Fernø J, Cet D, et al. Reprint of: recent updates on obesity treatments: Available drugs and future directions. Neuroscience. 2020;447:191–215.
Bhaskaran K, Douglas I, Forbes H, et al. Body-mass index and risk of 22 specific cancers: A population-based cohort study of 5·24 million UK adults. Lancet. 2014;384(9945):755–65.
Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body fatness and cancer-viewpoint of the IARC working group. N Engl J Med. 2016;375(8):794–8.
van de Donk N, Pawlyn C, Yong KL. Multiple myeloma. Lancet. 2021;397(10272):410–27.
Huang J, Chan SC, Lok V, et al. The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends. Lancet Haematol. 2022;9(9):e670–e7.
Avgerinos KI, Spyrou N, Mantzoros CS, et al. Obesity and cancer risk: emerging biological mechanisms and perspectives. Metabolism. 2019;92:121–35.
Ligibel JA, Alfano CM, Courneya KS, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014;32(31):3568–74.
Carson KR, Bates ML, Tomasson MH. The skinny on obesity and plasma cell myeloma: a review of the literature. Bone Marrow Transplant. 2014;49(8):1009–15.
Parikh R, Tariq SM, Marinac CR, et al. A comprehensive review of the impact of obesity on plasma cell disorders. Leukemia. 2022;36(2):301–14.
Morris EV, Suchacki KJ, Hocking J, et al. Myeloma cells Down-regulate adiponectin in bone marrow adipocytes via TNFalpha. J Bone Miner Res. 2020;35(5):942–55.
Park J, Scherer PE. Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest. 2012;122(11):4243–56.
Psaltopoulou T, Ntanasis-Stathopoulos I, Tsilimigras DI, et al. Micronutrient intake and risk of hematological malignancies in adults: a systematic review and meta-analysis of cohort studies. Nutr Cancer. 2018;70(6):821–39.
Psaltopoulou T, Sergentanis TN, Ntanasis-Stathopoulos I, et al. Anthropometric characteristics, physical activity and risk of hematological malignancies: A systematic review and meta-analysis of cohort studies. Int J Cancer. 2019;145(2):347–59.
Sergentanis TN, Ntanasis-Stathopoulos I, Tzanninis IG, et al. Meat, fish, dairy products and risk of hematological malignancies in adults - a systematic review and meta-analysis of prospective studies. Leuk Lymphoma. 2019;60(8):1978–90.
Perdomo CM, Cohen RV, Sumithran P, et al. Contemporary medical, device, and surgical therapies for obesity in adults. Lancet. 2023;401(10382):1116–30.
Colquitt JL, Pickett K, Loveman E, et al. Surgery for weight loss in adults. Cochrane Database Syst Rev. 2014(8):CD003641.
Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: development of standards for patient safety and efficacy. Metabolism. 2018;79:97–107.
Talebpour M, Sadid D, Talebpour A, et al. Comparison of short-term effectiveness and postoperative complications: laparoscopic gastric plication vs laparoscopic sleeve gastrectomy. Obes Surg. 2018;28(4):996–1001.
Brito H, Santos AC, Preto J, et al. Obesity and cancer: The profile of a population who underwent bariatric surgery. Obes Surg. 2021;31(11):4682–91.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. J Clin Epidemiol. 2021;134:178–89.
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.
Khalid SI, Maasarani S, Wiegmann J, et al. Association of bariatric surgery and risk of cancer in patients with morbid obesity. Ann Surg. 2022;275(1):1–6.
Aminian A, Wilson R, Al-Kurd A, et al. Association of bariatric surgery with cancer risk and mortality in adults with obesity. JAMA. 2022;327(24):2423–33.
Chittajallu V, Mansoor E, Perez J, et al. Association of Bariatric Surgery with risk of incident obesity-associated malignancies: a multi-center population-based study. Obes Surg. 2023;33(12):4065–9.
Rustgi VK, Li Y, Gupta K, et al. Bariatric surgery reduces cancer risk in adults with nonalcoholic fatty liver disease and severe obesity. Gastroenterology. 2021;161(1):171–84.e10.
Christou NV, Lieberman M, Sampalis F, et al. Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Relat Dis. 2008;4(6):691–5.
Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009;17(4):796–802.
Tao W, Santoni G, von Euler-Chelpin M, et al. Cancer risk after bariatric surgery in a cohort study from the five Nordic countries. Obes Surg. 2020;30(10):3761–7.
Tsui ST, Yang J, Zhang X, et al. Development of cancer after bariatric surgery. Surg Obes Relat Dis. 2020;16(10):1586–95.
Lazzati A, Epaud S, Ortala M, et al. Effect of bariatric surgery on cancer risk: results from an emulated target trial using population-based data. Br J Surg. 2022;109(5):433–8.
Adams LB, Chang C, Pope J, et al. Randomized, prospective comparison of ursodeoxycholic acid for the prevention of gallstones after sleeve gastrectomy. Obes Surg. 2016;26(5):990–4.
Bhupathiraju SN, Hu FB. Epidemiology of obesity and diabetes and their cardiovascular complications. Circ Res. 2016;118(11):1723–35.
Tentolouris A, Ntanasis-Stathopoulos I, Terpos E. Obesity and multiple myeloma: emerging mechanisms and perspectives. Semin Cancer Biol. 2023;92:45–60.
Wilson RB, Lathigara D, Kaushal D. Systematic review and meta-analysis of the impact of bariatric surgery on future cancer risk. Int J Mol Sci. 2023;24(7):6192.
Clapp B, Portela R, Sharma I, et al. Risk of non-hormonal cancer after bariatric surgery: meta-analysis of retrospective observational studies. Br J Surg. 2022;110(1):24–33.
Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg. 2023;33(1):3–14.
Benaiges D, Goday A, Pedro-Botet J, et al. Bariatric surgery: to whom and when? Minerva Endocrinol. 2015;40(2):119–28.
Kleinstern G, Larson DR, Allmer C, et al. Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota. Blood Cancer J. 2022;12(4):67.
Went M, Cornish AJ, Law PJ, et al. Search for multiple myeloma risk factors using Mendelian randomization. Blood Adv. 2020;4(10):2172–9.
Bullwinkle EM, Parker MD, Bonan NF, et al. Adipocytes contribute to the growth and progression of multiple myeloma: unraveling obesity related differences in adipocyte signaling. Cancer Lett. 2016;380(1):114–21.
Fairfield H, Dudakovic A, Khatib CM, et al. Myeloma-modified adipocytes exhibit metabolic dysfunction and a senescence-associated secretory phenotype. Cancer Res. 2021;81(3):634–47.
Li Y, Meng Y, Yu X. The unique metabolic characteristics of bone marrow adipose tissue. Front Endocrinol (Lausanne). 2019;10:69.
Giannakoulas N, Ntanasis-Stathopoulos I, Terpos E. The role of marrow microenvironment in the growth and development of malignant plasma cells in multiple myeloma. Int J Mol Sci. 2021;22(9):4462.
Fairfield H, Condruti R, Farrell M, et al. Development and characterization of three cell culture systems to investigate the relationship between primary bone marrow adipocytes and myeloma cells. Front Oncol. 2022;12:912834.
Mondello P, Cuzzocrea S, Navarra M, et al. Bone marrow micro-environment is a crucial player for myelomagenesis and disease progression. Oncotarget. 2017;8(12):20394–409.
Cui Y, Wang F, Zhang D, et al. Estrogen-responsive gene MAST4 regulates myeloma bone disease. J Bone Miner Res. 2022;37(4):711–23.
Morris EV, Edwards CM. Adipokines, adiposity, and bone marrow adipocytes: dangerous accomplices in multiple myeloma. J Cell Physiol. 2018;233(12):9159–66.
Bieghs L, Johnsen HE, Maes K, et al. The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential. Oncotarget. 2016;7(30):48732–52.
Lazaris V, Hatziri A, Symeonidis A, Kypreos KE. The lipoprotein transport system in the pathogenesis of multiple myeloma: advances and challenges. Front Oncol. 2021;11:638288.
Funding
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the Natural Science Foundation of Gansu Province (grant number 23JRRA1317).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Informed Consent
Informed Consent does not apply.
Ethical Approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Conflict of Interest
No conflict of interest.
Studies with Human Participants
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key Points.
• Bariatric surgery has an impact on cancer risk in obese individuals.
• Bariatric surgery has a potentially protective effect in reducing the risk of future MM in patients with obesity.
• Overall, bariatric surgery has resulted in a relative reduction in the incidence of MM of approximately 50%.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Wu, Q., Zhao, T., Zhu, C. et al. Correlation Between Bariatric Surgery and the Risk of Multiple Myeloma: Results from an Evidence-Based Strategy. OBES SURG 34, 1061–1072 (2024). https://doi.org/10.1007/s11695-024-07059-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-024-07059-x